北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 肾脏内科  > 期刊论文
学科主题: 临床医学
题名:
Aristolochic acid nephropathy: variation in presentation and prognosis
作者: Yang, Li1; Su, Tao1; Li, Xiao-Mei1; Wang, Xuan2; Cai, Shao-Qing2; Meng, Li-Qiang1; Zou, Wan-Zhong3; Wang, Hai-Yan1
关键词: aristolochic acid ; aristolochic acid nephropathy ; chronic kidney disease ; prognosis
刊名: NEPHROLOGY DIALYSIS TRANSPLANTATION
发表日期: 2012
DOI: 10.1093/ndt/gfr291
卷: 27, 期:1, 页:292-298
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Transplantation ; Urology & Nephrology
研究领域[WOS]: Transplantation ; Urology & Nephrology
关键词[WOS]: CHINESE HERBS NEPHROPATHY ; INTERSTITIAL RENAL FIBROSIS ; BALKAN ENDEMIC NEPHROPATHY ; FANCONIS-SYNDROME ; IDENTIFICATION ; PATIENT ; JAPAN
英文摘要:

Background. Aristolochic acid nephropathy (AAN) is a worldwide problem and one of the common causes of chronic kidney disease (CKD) in China.

Methods. Three hundred patients diagnosed as AAN from 1997 to 2006 were enrolled. Medical histories of Chinese herb ingestion, clinical-pathological features and risk factors for renal failure were recorded. Patients were followed up for 2-156 months. Factors involved in the prognosis of AAN were investigated.

Results. The 300 patients with AAN manifested three clinical subtypes, including acute kidney injury (acute AAN) in 13 patients, abrupt tubular dysfunction with normal serum creatinine (Scr) levels in seven cases and chronic tubulointerstitial nephropathy with decreased estimated glomerular filtration rate (eGFR) (chronic AAN) in 280 cases. The acute AAN cases had the highest aristolochic acid (AA)-I intake per day and developed progressive kidney failure during 1-7 years follow-up. The tubular dysfunction AAN patients had the lowest cumulative AA-I intake and were able to keep normal Scr levels during 2-8 years follow-up. The chronic AAN patients took the lowest AA-I dose per day but with the longest period and the highest cumulative dosage and exhibited a very large range of eGFR changing rate (from -21.6 to 5.2, median -3.5 mL/min/year). The cumulative AA-I intake (r = 0.330, P = 0.045) and the time course from the termination of AA medication to the start of follow-up (r = -0.430, P = 0.009) were found to be independent factors correlated with the decrease rate of eGFR in the chronic AAN patients. AA and the metabolites could be detected in a high frequency in patients who had stopped herbal medication for 1 year, which indicates a rather long washout time for these chemicals.

Conclusions. AAN has variant phenotypes with distinct prognosis, which is determined by the variable AA medications. With better understanding of toxic and environmental causes for kidney injury, there would be a better chance to uncover the causal factors of cases of ′CKD without known causes′ which is crucial for improving the disease outcomes.

语种: 英语
所属项目编号: 985-2001
项目资助者: Education Ministry of China
WOS记录号: WOS:000299957700044
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/59208
Appears in Collections:北京大学第一临床医学院_肾脏内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China
2.Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China
3.Peking Univ, Dept Pathol, Hosp 1, Beijing 100871, Peoples R China

Recommended Citation:
Yang, Li,Su, Tao,Li, Xiao-Mei,et al. Aristolochic acid nephropathy: variation in presentation and prognosis[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION,2012,27(1):292-298.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yang, Li]'s Articles
[Su, Tao]'s Articles
[Li, Xiao-Mei]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yang, Li]‘s Articles
[Su, Tao]‘s Articles
[Li, Xiao-Mei]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace